Skip navigation
Agenda

Collaborative Approaches for Risk Sharing, Population Health Management and Data-Driven Product Advancement

August 15-16, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE Wednesday, August 15, 2018

7:00

Registration and Continental Breakfast

8:00

Chairperson’s Welcome and Opening Remarks

Mark Fisher
Director – Key Account Lead, Joint Health and Renal
Sanofi Biosurgery

Assess the Shifting Focus of an Outcomes-Driven Marketplace for Payers and Providers

8:10

KEYNOTE ADDRESS Taking a Different Approach to Managing Total Cost of Care

Michael Hunt
DO, CEO, President
St. Vincent's Health Partners, Inc.

8:50

Partnering to Improve Speed to Market

MODERATOR:

Brandon Newman, PharmD, MMHC, CSP
Vice President, Clinical Affairs
Trellis Rx

CASE STUDY and Q&A:

Tim Gentilcore
Director – Retail Pharmacy
Mission Health System

Denali Cahoon, PharmD, CSP
VP and GM Mission Health Specialty Pharmacy
Trellis Rx

9:30

Value-Based Contracting at the Provider Level and Aligning Incentives

Michelle Templin
Vice President, Government Affairs and Business Development
MHA ACO Network

10:10

Networking and Refreshment Break

10:40

Mega-IDNs Rattle Payer Landscape

Josh Kelley
Senior Director, US Regional & Customer Segment Insights
Decision Resources Group

Mark Cherry
Principal Analyst, Market Access Insights
Decision Resources Group

11:20

Navigating Trends in the Plan Sponsor and Pharmacy Benefit Landscape

Jane Lutz
Executive Director
Pharmacy Benefit Management Institute (PBMI)

12:00

Networking Luncheon

1:00

Compare Evolving IDN Models with Medicare/Medicaid Requirements

Robert DeVol
Director, Healthcare Innovator's Collaborative
Premier Inc.

1:40

Learn How to Identify and Develop Meaningful Pharma-IDN Partnership Opportunities

Shiraz Hasan
Vice President
Precision Xtract (Part of Precision Value & Health)

Satish Valluri
Strategic Patient Access and Reimbursement, US Rare Disease
Pfizer Inc

Maureen Hennessey, PhD, CPCC
Senior Vice President, Director, Quality and Population Health Solutions
Precision for Value

2:20

Evolution of Pharmacy — Driving Future Innovations of Care

Suzette DiMascio, CHE, CMCE, CPC
President and CEO
CSI Specialty Group

3:00

Networking and Refreshment Break

3:30

IDN-SP PANEL IDNs in Transition —
Specialty Pharmacy Service Value Redesign for Total Patient Care

MODERATOR:

Erin Hendrick
Vice President, Hospital Strategy
Shields Health Solutions

PANELISTS:

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Jacob Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Ameet Wattamwar, PharmD
Assistant Director of Pharmacy, Specialty Pharmacy Program
NYU Langone Medical Center

Technological and Strategic Advances from the Specialty Pharmacy Perspective

4:10

Assess IDNs and Their Continued Evolution

Christopher Lisanti
Managing Partner
Exequor Group

Greg Allard
Partner
Exequor Group

4:50

From Strategy to Execution —
Developing an IDN Key Account Management Proof of Concept

Andy Pulvermacher
Principal Consultant
Blue Fin Group

Will Rose
Principal Consultant
Blue Fin Group

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one
Hosted by:

DAY TWO Thursday, August 16, 2018

7:00

Continental Breakfast

7:30

Chairperson’s Review of Day One

Mark Fisher
Director – Key Account Lead, Joint Health and Renal
Sanofi Biosurgery

7:40

Making an Impact —
How Technology Can Shape Successful Patient Care and Treatment Outcomes

Amy H. Seung, PharmD, BCOP
Senior Director, Clinical Development
AssistRx

8:20

OCHSNER HEALTH SYSTEM CASE STUDY Why Integration of Specialty Pharmacy Matters

Sheena Babin, PharmD
Manager, Business Development and Clinical Services
Ochsner Health System

9:00

NYU CASE STUDY Improving Health and Economic Outcomes

Ameet Wattamwar, Pharm.D.
Assistant Director of Pharmacy, Specialty Pharmacy Program
NYU Langone Medical Center

9:40

Networking and Refreshment Break

10:10

Real-World Evidence — When BioPharma and IDNs Collaborate

Scot Buchanan
Vice President, Biotech and Specialty Services
Therigy LLC

Rich Gourash
Vice President, Specialty Outcomes
Therigy LLC

10:50

Optimizing IDN Brand Access

Marc Duey
President, CEO
Prometrics

11:30

JOHNS HOPKINS CASE STUDY Utilizing Real-World Data to Measure Clinical Outcomes

Scott Canfield, PharmD
Assistant Director, Clinical Program Development
Johns Hopkins Home Care Group

12:10

Networking Luncheon

Ramp up Internal and External Resources for Better Partnership Opportunities

1:10

Patient Centered Pharma-IDN Partnerships Deliver More Value to Patients

Matt Schumacher
Agility Enablement Lead, Patient Value Unit – Neurology
UCB

1:50

Align Your Value Proposition to Your Customers' Needs

Scott Garrett
Respiratory Institutional Regional Business Manager
Sunovion Pharmaceuticals

2:30

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE Wednesday, August 15, 2018

7:00

Registration and Continental Breakfast

8:00

Chairperson’s Welcome and Opening Remarks

Mark Fisher
Director – Key Account Lead, Joint Health and Renal
Sanofi Biosurgery

Assess the Shifting Focus of an Outcomes-Driven Marketplace for Payers and Providers

8:10

KEYNOTE ADDRESS Taking a Different Approach to Managing Total Cost of Care

Michael Hunt
DO, CEO, President
St. Vincent's Health Partners, Inc.

8:50

Partnering to Improve Speed to Market

MODERATOR:

Brandon Newman, PharmD, MMHC, CSP
Vice President, Clinical Affairs
Trellis Rx

CASE STUDY and Q&A:

Tim Gentilcore
Director – Retail Pharmacy
Mission Health System

Denali Cahoon, PharmD, CSP
VP and GM Mission Health Specialty Pharmacy
Trellis Rx

9:30

Value-Based Contracting at the Provider Level and Aligning Incentives

Michelle Templin
Vice President, Government Affairs and Business Development
MHA ACO Network

10:10

Networking and Refreshment Break

10:40

Mega-IDNs Rattle Payer Landscape

Josh Kelley
Senior Director, US Regional & Customer Segment Insights
Decision Resources Group

Mark Cherry
Principal Analyst, Market Access Insights
Decision Resources Group

11:20

Navigating Trends in the Plan Sponsor and Pharmacy Benefit Landscape

Jane Lutz
Executive Director
Pharmacy Benefit Management Institute (PBMI)

12:00

Networking Luncheon

1:00

Compare Evolving IDN Models with Medicare/Medicaid Requirements

Robert DeVol
Director, Healthcare Innovator's Collaborative
Premier Inc.

1:40

Learn How to Identify and Develop Meaningful Pharma-IDN Partnership Opportunities

Shiraz Hasan
Vice President
Precision Xtract (Part of Precision Value & Health)

Satish Valluri
Strategic Patient Access and Reimbursement, US Rare Disease
Pfizer Inc

Maureen Hennessey, PhD, CPCC
Senior Vice President, Director, Quality and Population Health Solutions
Precision for Value

2:20

Evolution of Pharmacy — Driving Future Innovations of Care

Suzette DiMascio, CHE, CMCE, CPC
President and CEO
CSI Specialty Group

3:00

Networking and Refreshment Break

3:30

IDN-SP PANEL IDNs in Transition —
Specialty Pharmacy Service Value Redesign for Total Patient Care

MODERATOR:

Erin Hendrick
Vice President, Hospital Strategy
Shields Health Solutions

PANELISTS:

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Jacob Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Ameet Wattamwar, PharmD
Assistant Director of Pharmacy, Specialty Pharmacy Program
NYU Langone Medical Center

Technological and Strategic Advances from the Specialty Pharmacy Perspective

4:10

Assess IDNs and Their Continued Evolution

Christopher Lisanti
Managing Partner
Exequor Group

Greg Allard
Partner
Exequor Group

4:50

From Strategy to Execution —
Developing an IDN Key Account Management Proof of Concept

Andy Pulvermacher
Principal Consultant
Blue Fin Group

Will Rose
Principal Consultant
Blue Fin Group

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one
Hosted by:

DAY TWO Thursday, August 16, 2018

7:00

Continental Breakfast

7:30

Chairperson’s Review of Day One

Mark Fisher
Director – Key Account Lead, Joint Health and Renal
Sanofi Biosurgery

7:40

Making an Impact —
How Technology Can Shape Successful Patient Care and Treatment Outcomes

Amy H. Seung, PharmD, BCOP
Senior Director, Clinical Development
AssistRx

8:20

OCHSNER HEALTH SYSTEM CASE STUDY Why Integration of Specialty Pharmacy Matters

Sheena Babin, PharmD
Manager, Business Development and Clinical Services
Ochsner Health System

9:00

NYU CASE STUDY Improving Health and Economic Outcomes

Ameet Wattamwar, Pharm.D.
Assistant Director of Pharmacy, Specialty Pharmacy Program
NYU Langone Medical Center

9:40

Networking and Refreshment Break

10:10

Real-World Evidence — When BioPharma and IDNs Collaborate

Scot Buchanan
Vice President, Biotech and Specialty Services
Therigy LLC

Rich Gourash
Vice President, Specialty Outcomes
Therigy LLC

10:50

Optimizing IDN Brand Access

Marc Duey
President, CEO
Prometrics

11:30

JOHNS HOPKINS CASE STUDY Utilizing Real-World Data to Measure Clinical Outcomes

Scott Canfield, PharmD
Assistant Director, Clinical Program Development
Johns Hopkins Home Care Group

12:10

Networking Luncheon

Ramp up Internal and External Resources for Better Partnership Opportunities

1:10

Patient Centered Pharma-IDN Partnerships Deliver More Value to Patients

Matt Schumacher
Agility Enablement Lead, Patient Value Unit – Neurology
UCB

1:50

Align Your Value Proposition to Your Customers' Needs

Scott Garrett
Respiratory Institutional Regional Business Manager
Sunovion Pharmaceuticals

2:30

Close of Conference